PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32038265-0	2019	Protective Effect of Piceatannol Against Acute Lung Injury Through Protecting the Integrity of Air-Blood Barrier and Modulating the TLR4/NF-kappaB Signaling Pathway Activation.	3,3',4,5'-tetrahydroxystilbene	21-32	nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105	Mus musculus	137-146	
35208996-7	2022	Mechanism investigations suggested that piceatannol inhibited NF-kappaB and MAPK activation.	3,3',4,5'-tetrahydroxystilbene	40-51	nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105	Mus musculus	62-71	
35208996-8	2022	Taken together, these observations suggest that piceatannol reduces inflammation and oxidative stress through inactivating the NF-kappaB and MAPK signaling pathways on cerebral endothelial cells in vitro.	3,3',4,5'-tetrahydroxystilbene	48-59	nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105	Mus musculus	127-136	
32038265-10	2019	We also found that PIC remarkably restrained the LPS-induced TLR4/NF-kappaB pathway activation in lung tissues.	3,3',4,5'-tetrahydroxystilbene	19-22	nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105	Mus musculus	66-75	
32038265-11	2019	In conclusion, PIC may be potential to treat LPS-induced acute lung injury (ALI) via regulating air-blood barrier and TLR4/NF-kappaB signaling pathway activation.	3,3',4,5'-tetrahydroxystilbene	15-18	nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105	Mus musculus	123-132	
20155626-6	2009	Oral administration of resveratrol or piceatannol (10 mg/kg body weight each) for 7 constitutive days attenuated the DSS-induced inflammatory injury, upregulation of iNOS expression, and activation of NF-kappaB, STAT3, and ERK.	3,3',4,5'-tetrahydroxystilbene	38-49	nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105	Mus musculus	201-210	
28933476-6	2017	Mechanistically, we found that piceatannol inhibited IL-1beta-induced nuclear factor kappa B (NF-kappaB) activation by activating the nuclear factor (erythroid-derived 2)-like 2 (Nrf2)/heme oxygenase 1 (HO-1) pathway.	3,3',4,5'-tetrahydroxystilbene	31-42	nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105	Mus musculus	70-92	
28933476-6	2017	Mechanistically, we found that piceatannol inhibited IL-1beta-induced nuclear factor kappa B (NF-kappaB) activation by activating the nuclear factor (erythroid-derived 2)-like 2 (Nrf2)/heme oxygenase 1 (HO-1) pathway.	3,3',4,5'-tetrahydroxystilbene	31-42	nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105	Mus musculus	94-103	
20155626-0	2009	Resveratrol and piceatannol inhibit iNOS expression and NF-kappaB activation in dextran sulfate sodium-induced mouse colitis.	3,3',4,5'-tetrahydroxystilbene	16-27	nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105	Mus musculus	56-65	
15502405-0	2004	Piceatannol prevents lipopolysaccharide (LPS)-induced nitric oxide (NO) production and nuclear factor (NF)-kappaB activation by inhibiting IkappaB kinase (IKK).	3,3',4,5'-tetrahydroxystilbene	0-11	nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105	Mus musculus	87-113	
15502405-4	2004	The inhibitory effect of piceatannol was mediated by down-regulation of LPS-induced nuclear factor (NF)-kappaB activation, but not by its cytotoxic action.	3,3',4,5'-tetrahydroxystilbene	25-36	nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105	Mus musculus	84-110